BCN PEPTIDES SA
Overview
BCN PEPTIDES SA is an active pharmaceutical ingredient (API) supplier with 12 active FDA Type II Drug Master Files, covering ANGIOTENSIN II; CETRORELIX; DESMOPRESSIN ACETATE; GANIRELIX ACETATE; ICATIBANT ACETATE; LANREOTIDE.
Core services & business areas
Active pharmaceutical ingredients supplied
Substances BCN PEPTIDES SA is evidenced to supply (US FDA Drug Master File or EU CEP). Open any ingredient to see its full supplier landscape, CAS number and patent status.
API / Drug Master Files
BCN PEPTIDES SA holds 12 active (12 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.
- LANREOTIDEActive2023-12-21
- CETRORELIXActive2023-03-31
- ANGIOTENSIN IIActive2021-10-04
- GANIRELIX ACETATEActive2015-07-24
- ICATIBANT ACETATEActive2015-03-26
- LEUPROLIDE (LEUPRORELIN)Active2012-12-11
- NESIRITIDEActive2012-12-04
- VASOPRESSINActive2012-01-24
- SALMON CALCITONINActive2006-07-05
- DESMOPRESSIN ACETATEActive2006-04-06
- TETRACOSACTIDEActive2005-11-18
- OCTREOTIDE ACETATEActive2005-09-08
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to BCN PEPTIDES SA in our records. PharmaTek screens the full directory against live FDA enforcement data.
Is this BCN PEPTIDES SA? Get in front of buyers actively sourcing.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.